Management of Wilson Disease Diagnosed in Infancy: An Appraisal of Available Experience to Generate Discussion
Overview
Authors
Affiliations
Increased access to molecular genetic testing is changing the demographics for diagnosing inherited disorders and imposing new challenges for medical management. Wilson disease (WD), typically diagnosed in older children and adults, can now be detected in utero and in infants (children younger than 24 months, including neonates) via genetic testing. An evidence-based approach to management of these neonates and extremely young children, who are typically asymptomatic, has been hampered by lack of clinical experience. We present a case of an infantile diagnosis of WD, review available experience, and discuss current trends in antenatal genetic testing of parents and fetus that may lead to a very early diagnosis of WD. Based on physiological and nutritional considerations, we propose an algorithmic approach to management of infantile WD as a starting point for further discussion. Future collaboration amongst specialists is essential to identify evidence-based approaches and best practice for managing treatment of infants with genetically diagnosed WD.
Low Copper Diet-A Therapeutic Option for Wilson Disease?.
Teufel-Schafer U, Forster C, Schaefer N Children (Basel). 2022; 9(8).
PMID: 36010023 PMC: 9406399. DOI: 10.3390/children9081132.
Mutation spectrum of gene in pediatric patients with Wilson disease in Vietnam.
Huong N, Hoa N, Ngoc N, Mai N, Hai Yen P, Anh H Mol Genet Metab Rep. 2022; 31:100861.
PMID: 35782615 PMC: 9248214. DOI: 10.1016/j.ymgmr.2022.100861.
Designing Clinical Trials in Wilson's Disease.
Ott P, Ala A, Askari F, Czlonkowska A, Hilgers R, Poujois A Hepatology. 2021; 74(6):3460-3471.
PMID: 34320232 PMC: 9291486. DOI: 10.1002/hep.32074.